David Moreno

David Moreno is an experienced finance professional currently serving as Associate Director at Nektar Therapeutics since April 2021. With a strong background in financial management and analysis, David has previously held positions including Sr. Business Analyst at KCI USA, where expertise in process optimization and cost reduction was demonstrated, and Senior Finance Manager at CellRight Technologies, overseeing accounting and finance for US operations. David's career also includes significant roles at Shire and Baxalta focusing on inventory and business performance management, along with foundational experience at Baxter and Cardinal Health in financial planning and analysis. David earned a BBA in Finance from the University of Texas at El Paso (UTEP) from 2003 to 2005.